fibrinogen has been researched along with Diabetic Glomerulosclerosis in 70 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 19 (27.14) | 18.7374 |
1990's | 20 (28.57) | 18.2507 |
2000's | 16 (22.86) | 29.6817 |
2010's | 9 (12.86) | 24.3611 |
2020's | 6 (8.57) | 2.80 |
Authors | Studies |
---|---|
Chen, L; Tan, HB; Zhao, Q | 1 |
Fei, X; Han, F; Pan, L; Wo, M; Wu, Y; Xu, C; Ye, Y; Zhu, F | 1 |
Giribabu, N; Kilari, EK; Salleh, N; Wahab, NAA | 1 |
Wang, X; Wei, H; Yang, C; Yang, Y; Zhang, T; Zhang, Y; Zhao, Q | 1 |
Cai, Y; Shang, J; Simmons, D; Wang, Z; Yu, D; Zhao, B; Zhao, Z | 1 |
Chen, JG; Peng, TW; Xu, GQ; Zhang, HB; Zhang, YH; Zhao, SC; Zuo, Y | 1 |
Chauhan, AK; Chorawala, MR; Dhanesha, N; Doddapattar, P; Kokame, K; Lentz, SR; Nayak, MK; Staber, JM | 1 |
Guo, R; Han, Q; Li, H; Li, L; Liu, F; Wang, S; Wang, T; Wang, Y; Wu, Y; Zhang, J; Zhang, R | 1 |
Sun, F; Teng, J; Wang, D; Yu, PF | 1 |
C-K Chou, C; Cheng, TJ; Li, YR; Lo, K; Tung, CL; Wang, JS; Yan, YH | 1 |
Ahn, CW; Kang, S; Kim, KR; Lee, MY; Lee, S; Nam, JS; Park, JS; Shin, S | 1 |
Hirschberg, R; Mitu, G | 1 |
Cornell, E; Knowler, WC; Krakoff, J; Le, DS; Miles, R; Savage, PJ; Tracy, RP | 1 |
Aita, CA; Fortes, PC; Marcondes, LB; Mendes, JG; Pecoits-Filho, R; Riella, MC; Sesiuk, K | 1 |
de Gorospe Pérez-Jáuregui, C; Del Cañizo Gómez, FJ; Fernández Pérez, C; González Losada, T; Moreno Ruiz, I; Segura Galindo, A; Silveira Rodríguez, B | 1 |
Tanriverdı, O | 1 |
Howard, KP; Klein, BE; Klein, R; Lee, KE | 1 |
Clore, J; Garvey, WT; Hunter, SJ; Jenkins, AJ; Klein, RL; Semler, AJ; Zheng, D | 1 |
Bargero, G; Biggeri, A; Bruno, G; Cavallo Perin, P; Ferrero, S; Merletti, F; Pagano, G | 1 |
Kammerer, L; Lengyel, Z; Mihály, M; Németh, C; Rosivall, L; Tornóci, L; Tóth, LK; Vörös, P | 1 |
Chiba, E | 1 |
Gomes, MB; Nogueira, VG | 1 |
Aso, Y; Inukai, T; Matsutomo, R; Okumura, K; Takebayashi, K; Wakabayashi, S; Yoshida, N | 1 |
Famodu, AA; Umunna, CE; Unuigbe, EI | 1 |
Ansquer, JC; Foucher, C; Rattier, S; Steiner, G; Taskinen, MR | 1 |
Mora, C; Navarro, JF | 1 |
Barazzoni, R; Kiwanuka, E; Tessari, P; Vettore, M; Zanetti, M | 1 |
He, LJ; He, XH; Lan, LG; Lu, AH; Min, XL; Zhao, L; Zhu, LQ | 1 |
Castellino, P; Ciarambino, T; Cioffi, M; De Feo, P; Gesuè, L; Giordano, M; Gresele, P; Lucidi, P; Paolisso, G | 1 |
Berger, W; Christe, M; Duckert, F; Fritschi, J; Lämmle, B; Marbet, GA; Tran, TH | 1 |
Endoh, M; Jinde, K; Koji, T; Miyazaki, M; Naka, R; Nomoto, Y; Sakai, H; Suzuki, D; Yagame, M | 1 |
Federman, SM; Krolewski, AS; Lipinski, B | 1 |
Bent-Hansen, L | 1 |
Deckert, T; Jensen, JS; Jensen, T; Yokoyama, H | 1 |
Abendroth, D; Land, W; Landgraf, R; Pfeiffer, M; Reininger, J; Seidel, D | 1 |
Becker, DJ; Bunker, CH; Coonrod, BA; Drash, AL; Ellis, D; Kelsey, SF; Kuller, LH; Lloyd, CE; Orchard, TJ | 1 |
Egawa, H; Komiyama, Y; Murakami, T; Murata, K | 1 |
Best, J; Bourke, C; Janus, E; Jenkins, A; Lee, P; Paton, C; Santamaria, J | 1 |
Becker, DJ; Ellis, D; Kuller, LH; Lloyd, CE; Orchard, TJ; Wing, RR | 1 |
Biesenbach, G; Zazgornik, J | 1 |
Cavallo-Perin, P; D'Este, P; Girotto, M; Gruden, G; Mormile, A; Rossetto, P; Veglio, M | 1 |
de Maat, M; Gram, J; Jespersen, J; Kluft, C; Myrup, B; Rossing, P | 1 |
Andreani, D; Arcieri, P; Bosco, D; Ciampalini, P; Gargiulo, P; Pantaleo, A; Romani, B; Schiaffini, R | 1 |
D'Elia, JA; Gleason, RE; Keough, J; Weinrauch, LA | 1 |
Mojto, V | 1 |
Deckert, T; Gram, J; Jensen, T; Jespersen, J; Kluft, C; Myrup, B | 1 |
Demiroglu, H; Gürlek, A | 1 |
Babaya, N; Fujisawa, T; Fukuda, M; Ikegami, H; Kawabata, Y; Kawaguchi, Y; Nishino, T; Nojima, K; Noso, S; Ogihara, T; Ohguro, N; Okamoto, N; Ono, M; Shintani, M; Ueda, H; Yamada, K; Yamato, E | 1 |
Gram, J; Hølmer, G; Jensen, T; Jespersen, J; Kluft, C; Myrup, B; Parving, HH; Rossing, P | 1 |
Asakawa, H; Kawakami, F; Tokunaga, K | 1 |
Kösters, W | 1 |
Kawai, C; Nagai, T | 1 |
Bilo, HJ; Hardeman, MR; Michels, RP; Schut, NH; van Arkel, EC; Vreeken, J | 1 |
Karam, JH; Koda-Kimble, MA; White, JR | 1 |
Bielawiec, M; Kinalska, I; Kłoczko, J; Wojtukiewicz, M; Zarzycka, B | 1 |
Bock, KD; Graben, N; Gries, E; Paar, D | 1 |
Deckert, T; Jensen, T; Stender, S | 1 |
Bent-Hansen, L; Deckert, T | 1 |
Ferrari, E; Fioravanti, M; Patti, AL; Solerte, SB; Viola, C | 1 |
Bock, T; Ladik, T; Landgraf, R; Landgraf-Leurs, MM; Schramm, W; Smolka, B; Spannagl, M | 1 |
Fioravanti, M; Solerte, SB | 1 |
Duchna, W; Gräfenstein, K | 1 |
Carstairs, KC; Davies, MJ; Woolf, N | 1 |
Thomsen, OF | 1 |
Farquhar, A; Ireland, JT; MacDonald, MK | 1 |
George, CR; Harker, LA; Quadracci, LJ; Slichter, SJ; Striker, GE | 1 |
Brown, DM; Fish, AJ; Mauer, SM; Michael, AF | 1 |
Clarkson, AR; Davison, AM; MacDonald, MK | 1 |
Valdorf-Hansen, F | 1 |
Losowsky, MS; Walls, WD | 1 |
2 review(s) available for fibrinogen and Diabetic Glomerulosclerosis
Article | Year |
---|---|
Bone morphogenetic protein-7 (BMP7) in chronic kidney disease.
Topics: Bone Morphogenetic Protein 3; Bone Morphogenetic Protein 7; Bone Morphogenetic Protein Receptors; Bone Morphogenetic Proteins; Chronic Disease; Diabetic Nephropathies; Fibrinogen; Gene Expression Regulation; Humans; Inhibins; Kidney; Kidney Diseases; Renal Insufficiency; Transforming Growth Factor beta | 2008 |
The role of inflammation as a pathogenic factor in the development of renal disease in diabetes.
Topics: Animals; Biomarkers; C-Reactive Protein; Cytokines; Diabetic Nephropathies; Disease Progression; Fibrinogen; Humans; Inflammation; Prognosis; Serum Amyloid A Protein | 2005 |
6 trial(s) available for fibrinogen and Diabetic Glomerulosclerosis
Article | Year |
---|---|
Fenofibrate reduces progression to microalbuminuria over 3 years in a placebo-controlled study in type 2 diabetes: results from the Diabetes Atherosclerosis Intervention Study (DAIS).
Topics: Albuminuria; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Body Mass Index; Creatinine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Disease Progression; Double-Blind Method; Female; Fenofibrate; Fibrinogen; Follow-Up Studies; Glycated Hemoglobin; Homocysteine; Humans; Hyperlipidemias; Hypertension; Hypolipidemic Agents; Incidence; Male; Middle Aged; Models, Biological; Smoking; Treatment Outcome | 2005 |
[Integrated treatment of traditional Chinese medicine and western medicine for early- and intermediate-stage diabetic nephropathy].
Topics: Aged; Albuminuria; Blood Glucose; Diabetic Nephropathies; Female; Fibrinogen; Humans; Integrative Medicine; Kidney; Male; Medicine, Chinese Traditional; Middle Aged; Time Factors; Treatment Outcome | 2007 |
Diabetic microangiopathy and blood viscosity changes after pancreas and kidney transplantation.
Topics: Adult; Blood Viscosity; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Diabetic Nephropathies; Female; Fibrinogen; Glycated Hemoglobin; Humans; Kidney Transplantation; Male; Middle Aged; Pancreas Transplantation; Probability; Rheology; Skin; Treatment Outcome | 1994 |
Elevated fibrinogen and the relation to acute phase response in diabetic nephropathy.
Topics: Acute-Phase Reaction; C-Reactive Protein; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Fibrinogen; Humans; Interleukin-6 | 1996 |
No effect of unfractioned or low molecular weight heparin treatment on markers of vascular wall and hemostatic function in incipient diabetic nephropathy.
Topics: Adult; Albuminuria; Antithrombin III; Capillaries; Cardiovascular Diseases; Cholesterol; Cholesterol, HDL; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Diabetic Nephropathies; Double-Blind Method; Female; Fibrinogen; Hemostasis; Heparin; Heparin, Low-Molecular-Weight; Humans; Male; Middle Aged; Muscle, Smooth, Vascular; Peptide Fragments; Peptide Hydrolases; Placebos; Plasminogen Activator Inhibitor 1; Protein Precursors; Prothrombin; Tissue Plasminogen Activator; Triglycerides; von Willebrand Factor | 1997 |
Lack of effect of fish oil supplementation on coagulation and transcapillary escape rate of albumin in insulin-dependent diabetic patients with diabetic nephropathy.
Topics: Antithrombin III; beta-Thromboglobulin; Blood Coagulation; Blood Platelets; Capillaries; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Double-Blind Method; Factor VII; Fatty Acids, Omega-3; Fibrinogen; Fibrinolysis; Fish Oils; Glycated Hemoglobin; Humans; Iodine Radioisotopes; Lipids; Olive Oil; Peptide Fragments; Peptide Hydrolases; Placebos; Plant Oils; Platelet Factor 4; Prothrombin; Serum Albumin; Serum Albumin, Radio-Iodinated; Thrombomodulin; von Willebrand Factor | 2001 |
62 other study(ies) available for fibrinogen and Diabetic Glomerulosclerosis
Article | Year |
---|---|
Penehyclidine hydrochloride suppresses inflammation response and reduces podocyte injury in diabetic nephropathy by targeting fibrinogen-like protein 2.
Topics: Animals; Caspase 1; Diabetes Mellitus; Diabetic Nephropathies; Female; Fibrinogen; Humans; Inflammation; Male; NF-kappa B; NLR Family, Pyrin Domain-Containing 3 Protein; Podocytes; Quinuclidines; Rats; Toll-Like Receptor 4 | 2022 |
Predictive significance of joint plasma fibrinogen and urinary alpha-1 microglobulin-creatinine ratio in patients with diabetic kidney disease.
Topics: Biomarkers; Creatinine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Fibrinogen; Humans; Retrospective Studies | 2022 |
Abietic acid ameliorates nephropathy progression via mitigating renal oxidative stress, inflammation, fibrosis and apoptosis in high fat diet and low dose streptozotocin-induced diabetic rats.
Topics: Abietanes; Animals; Anti-Inflammatory Agents; bcl-2-Associated X Protein; Blood Glucose; Caspase 3; Caspase 9; Creatinine; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Diet, High-Fat; Fibrinogen; Fibrosis; Glycogen Synthase Kinase 3 beta; Inflammation; Insulins; Interleukin-6; Kelch-Like ECH-Associated Protein 1; Kidney; Male; NF-E2-Related Factor 2; NF-kappa B; Oxidative Stress; Rats; Streptozocin; Superoxide Dismutase; Transforming Growth Factor beta1; Tumor Necrosis Factor-alpha | 2022 |
Establishment of a potent weighted risk model for determining the progression of diabetic kidney disease.
Topics: Cross-Sectional Studies; Diabetes Mellitus; Diabetic Nephropathies; Fibrinogen; Glycated Hemoglobin; Humans; Uric Acid | 2023 |
A low-cost laboratory-based method for predicting newly diagnosed biopsy-proven diabetic nephropathy in people with type 2 diabetes.
Topics: Aged; Biopsy; Blood Cell Count; Blood Chemical Analysis; Blood Coagulation Tests; Blood Glucose; Blood Pressure; Body Mass Index; China; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Glycated Hemoglobin; Humans; Kidney; Male; Middle Aged; Multivariate Analysis; Partial Thromboplastin Time; Prognosis; Risk Assessment; Thrombin Time | 2020 |
[Vascular damage-related risk factors for erectile dysfunction in patients with type 2 diabetes mellitus: Analysis based on a nomogram model].
Topics: Carotid Intima-Media Thickness; Cholesterol, LDL; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diabetic Retinopathy; Erectile Dysfunction; Erythrocyte Indices; Fibrinogen; Humans; Male; Nomograms; Risk Factors | 2020 |
ADAMTS13 Retards Progression of Diabetic Nephropathy by Inhibiting Intrarenal Thrombosis in Mice.
Topics: ADAMTS13 Protein; Albuminuria; Animals; Cell Proliferation; Creatinine; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Progression; Extracellular Matrix; Fibrinogen; Genetic Predisposition to Disease; Kidney Glomerulus; Male; Mice, Inbred C57BL; Mice, Knockout; Phenotype; Plasminogen Activator Inhibitor 1; Platelet Membrane Glycoprotein IIb; Streptozocin; Thrombosis; Urea; von Willebrand Factor | 2017 |
Serum fibrinogen predicts diabetic ESRD in patients with type 2 diabetes mellitus.
Topics: Cohort Studies; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Disease Progression; Female; Fibrinogen; Humans; Kidney; Kidney Failure, Chronic; Male; Middle Aged; Prognosis; Retrospective Studies | 2018 |
MicroRNA-488 regulates diabetic nephropathy via TGF-β1 pathway.
Topics: Cell Line; Collagen; Diabetic Nephropathies; Disease Progression; Fibrinogen; Fibronectins; Gene Knockdown Techniques; Glucose; Humans; Mesangial Cells; MicroRNAs; Signal Transduction; Transforming Growth Factor beta1 | 2019 |
Subchronic effects of inhaled ambient particulate matter on glucose homeostasis and target organ damage in a type 1 diabetic rat model.
Topics: Animals; Biomarkers; Blood Glucose; Diabetes Complications; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Diabetic Cardiomyopathies; Diabetic Nephropathies; Fibrinogen; Glycated Hemoglobin; Homeostasis; Inflammation; Inflammation Mediators; Inhalation Exposure; Interleukin-6; Male; Myocarditis; Particle Size; Particulate Matter; Rats, Sprague-Dawley; Risk Factors; Streptozocin; Time Factors; Toxicity Tests, Subchronic | 2014 |
Hemorheological Approach for Early Detection of Chronic Kidney Disease and Diabetic Nephropathy in Type 2 Diabetes.
Topics: Albuminuria; Biomarkers; Creatinine; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Early Diagnosis; Erythrocyte Aggregation; Erythrocyte Deformability; Fasting; Female; Fibrinogen; Glomerular Filtration Rate; Humans; Male; Middle Aged; Regression Analysis; Renal Insufficiency, Chronic | 2015 |
The association of plasma fibrinogen concentration with diabetic microvascular complications in young adults with early-onset of type 2 diabetes.
Topics: Adult; Albumins; Biomarkers; Cardiovascular Diseases; Creatinine; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Diabetic Retinopathy; Fibrinogen; Humans; Indians, North American; Inflammation; Microcirculation | 2008 |
Glycemic and lipidic profile in diabetic patients undergoing dialysis.
Topics: Biomarkers; Blood Glucose; Cardiovascular Diseases; Diabetic Nephropathies; Epidemiologic Methods; Female; Fibrinogen; Glycated Hemoglobin; Humans; Lipids; Male; Middle Aged; Patient Care Team; Peritoneal Dialysis; Renal Dialysis | 2010 |
Microvascular complications and risk factors in patients with type 2 diabetes.
Topics: Aged; Albuminuria; Anthropometry; Antihypertensive Agents; Blood Glucose; C-Reactive Protein; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Diabetic Retinopathy; Female; Fibrinogen; Follow-Up Studies; Glycated Hemoglobin; Habits; Humans; Hypoglycemic Agents; Lipids; Male; Microcirculation; Middle Aged; Prospective Studies; Risk Factors | 2011 |
Association of Helicobacter pylori infection with microalbuminuria in type 2 diabetic patients.
Topics: Adult; Aged; Albuminuria; Blood Sedimentation; C-Reactive Protein; Case-Control Studies; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Disease Progression; Female; Fibrinogen; Helicobacter Infections; Helicobacter pylori; Humans; Leukocyte Count; Lipoprotein(a); Logistic Models; Male; Middle Aged; Platelet Count; Statistics, Nonparametric | 2011 |
Cross-sectional associations of blood elements, clotting factors, nephropathy, and retinal outcomes in long duration type 1 diabetes.
Topics: Adult; Cross-Sectional Studies; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Diabetic Retinopathy; Enzyme-Linked Immunosorbent Assay; Female; Fibrinogen; Hematocrit; Humans; Interleukin-6; Leukocyte Count; Male; Odds Ratio; Platelet Count; von Willebrand Factor; Wisconsin | 2012 |
Fibrinogen is a marker for nephropathy and peripheral vascular disease in type 1 diabetes: studies of plasma fibrinogen and fibrinogen gene polymorphism in the DCCT/EDIC cohort.
Topics: Adenine; Adult; Albuminuria; Base Sequence; Biomarkers; Cohort Studies; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Diabetic Nephropathies; Diabetic Retinopathy; DNA Primers; Female; Fibrinogen; Guanine; Humans; Male; Peripheral Vascular Diseases; Polymorphism, Single Nucleotide; Regression Analysis | 2003 |
Progression to overt nephropathy in type 2 diabetes: the Casale Monferrato Study.
Topics: Aged; Albuminuria; Apolipoproteins B; Biomarkers; Cholesterol, HDL; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Disease Progression; Female; Fibrinogen; Follow-Up Studies; Glycated Hemoglobin; Humans; Hypertension; Male; Patient Selection; Prospective Studies; Regression Analysis; Risk Factors; Smoking; Time Factors | 2003 |
Urinary albumin excretion is correlated to fibrinogen levels and protein S activity in patients with type 1 diabetes mellitus without overt diabetic nephropathy.
Topics: Adult; Age Factors; Albuminuria; Blood Coagulation Tests; Body Mass Index; Data Interpretation, Statistical; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diabetic Retinopathy; Female; Fibrinogen; Humans; Male; Middle Aged; Protein S; Sex Factors | 2004 |
[Evaluations of double filtration plasma perfusion (DFPP) for arteriosclerosis obliterans (ASO) in maintenance hemodialysis patients].
Topics: Arteriosclerosis Obliterans; Combined Modality Therapy; Diabetic Nephropathies; Female; Fibrinogen; Humans; Hypertension; Male; Phosphorus; Plasmapheresis; Renal Dialysis; Treatment Outcome | 2004 |
Acute-phase proteins and microalbuminuria among patients with type 2 diabetes.
Topics: Acute-Phase Proteins; Age of Onset; Albuminuria; Blood Proteins; C-Reactive Protein; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Fibrinogen; Humans; Male; Middle Aged; Orosomucoid; Reference Values; Regression Analysis | 2004 |
Coagulation and inflammation in overt diabetic nephropathy: association with hyperhomocysteinemia.
Topics: Albuminuria; alpha-2-Antiplasmin; Biomarkers; Blood Coagulation; Creatinine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Fibrinogen; Fibrinolysin; Fibrinolysis; Homocysteine; Humans; Hyperhomocysteinemia; Inflammation; Interleukin-6; Linear Models; Male; Middle Aged; Protein C | 2004 |
Fibrinolytic activity in Nigerian diabetics with renal insufficiency.
Topics: Adult; Aged; Blood Coagulation Tests; Creatinine; Diabetes Mellitus; Diabetic Nephropathies; Female; Fibrinogen; Fibrinolysis; Humans; Kidney Failure, Chronic; Male; Middle Aged; Nigeria; Renal Insufficiency | 2005 |
Diabetic nephropathy is associated with increased albumin and fibrinogen production in patients with type 2 diabetes.
Topics: Albuminuria; C-Reactive Protein; Creatinine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Fibrinogen; Humans; Middle Aged; Serum Albumin | 2006 |
Effects of dietary protein restriction on albumin and fibrinogen synthesis in macroalbuminuric type 2 diabetic patients.
Topics: Adult; Albumins; Case-Control Studies; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diet, Protein-Restricted; Dietary Proteins; Female; Fibrinogen; Humans; Leucine; Male; Middle Aged; Proteinuria; Treatment Outcome | 2008 |
Fifteen coagulation and fibrinolysis parameters in diabetes mellitus and in patients with vasculopathy.
Topics: Adult; Age Factors; Aged; alpha-2-Antiplasmin; alpha-Macroglobulins; Antithrombin III; Arterial Occlusive Diseases; Blood Coagulation; Blood Coagulation Tests; Diabetes Mellitus; Diabetic Angiopathies; Diabetic Nephropathies; Diabetic Retinopathy; Factor VIII; Fibrinogen; Fibrinolysis; Humans; Middle Aged; Thrombin Time | 1984 |
In situ hybridization of interleukin 6 in diabetic nephropathy.
Topics: Adolescent; Adult; Biopsy; Blood Urea Nitrogen; Cell Division; Creatinine; Diabetic Nephropathies; Female; Fibrinogen; Glomerular Filtration Rate; Glomerular Mesangium; Glycated Hemoglobin; Humans; In Situ Hybridization; Interleukin-6; Kidney; Male; Middle Aged; Proteinuria; RNA, Messenger | 1995 |
Plasma macromolecular protein complex: interaction with fibrin and fibrinolysis.
Topics: Adult; Blood Coagulation; Blood Proteins; Chromatography, Gel; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Female; Fibrin; Fibrinogen; Fibrinolysis; Humans; Male; Protein Denaturation | 1995 |
Plasma disappearance and distribution volume of polyfructosan in type 1 (insulin-dependent) diabetes mellitus.
Topics: Albuminuria; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Fibrinogen; Fructans; Humans; Iodine Radioisotopes; Kidney; Male; Metabolic Clearance Rate; Models, Biological; Reference Values; Time Factors | 1994 |
Serum sialic acid concentration is elevated in IDDM especially in early diabetic nephropathy.
Topics: Adult; Blood Glucose; Blood Sedimentation; Creatinine; Cross-Sectional Studies; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Female; Fibrinogen; Glycated Hemoglobin; Humans; Male; Middle Aged; N-Acetylneuraminic Acid; Sialic Acids | 1995 |
Predictors of microalbuminuria in individuals with IDDM. Pittsburgh Epidemiology of Diabetes Complications Study.
Topics: Adult; Albuminuria; Apolipoprotein A-I; Apolipoprotein A-II; Apolipoproteins B; Biomarkers; Blood Pressure; Cholesterol, HDL; Cholesterol, LDL; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Female; Fibrinogen; Glycated Hemoglobin; Humans; Hypertension; Male; Prospective Studies; Reference Values; Risk Factors; Sex Factors; Triglycerides | 1993 |
Elevation of factor XIa-alpha 1-antitrypsin complex levels in NIDDM patients with diabetic nephropathy.
Topics: Albuminuria; alpha 1-Antitrypsin; Antithrombin III; Biomarkers; Blood Glucose; Blood Pressure; Cholesterol; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Enzyme-Linked Immunosorbent Assay; Factor XIa; Female; Fibrinogen; Glycated Hemoglobin; Humans; Insulin; Male; Middle Aged; Regression Analysis; Thrombin; Triglycerides | 1993 |
Prothrombotic and antithrombotic factors are elevated in patients with type 1 diabetes complicated by microalbuminuria.
Topics: Adult; Albuminuria; Antithrombin III; Blood Coagulation Tests; Cholesterol; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Factor VII; Female; Fibrinogen; Humans; Male; Protein C; Protein S; Prothrombin; Reference Values; Triglycerides | 1993 |
Coronary artery disease in IDDM. Gender differences in risk factors but not risk.
Topics: Adolescent; Adult; Age of Onset; Angina Pectoris; Body Constitution; Comorbidity; Coronary Disease; Depression; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Diabetic Retinopathy; Female; Fibrinogen; Follow-Up Studies; Humans; Hypertension; Hypertriglyceridemia; Lipids; Male; Motor Activity; Myocardial Infarction; Proportional Hazards Models; Risk; Risk Factors; Sex Factors; Smoking | 1996 |
Influence of smoking on the survival rate of diabetic patients requiring hemodialysis.
Topics: Blood Pressure; Cardiovascular Diseases; Cerebrovascular Disorders; Cholesterol; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Female; Fibrinogen; Glycated Hemoglobin; Humans; Kidney Failure, Chronic; Male; Middle Aged; Prevalence; Renal Dialysis; Retrospective Studies; Risk Assessment; Risk Factors; Smoking; Survival Rate; Time Factors; Triglycerides | 1996 |
Physiological inhibitors of blood coagulation and prothrombin fragment F 1 + 2 in type 2 diabetic patients with normoalbuminuria and incipient nephropathy.
Topics: Albuminuria; Anticoagulants; Antithrombin III; Blood Coagulation Factors; Blood Pressure; Body Mass Index; Cholesterol, HDL; Cholesterol, LDL; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Fibrinogen; Humans; Male; Middle Aged; Peptide Fragments; Protein C; Protein Precursors; Protein S; Prothrombin; Thrombomodulin; Triglycerides | 1996 |
Diabetic microangiopathy: lupus anticoagulant dependent thrombotic tendency in type 1 (insulin-dependent) diabetes mellitus.
Topics: Adult; Aged; Blood Coagulation; Blood Pressure; Body Mass Index; Creatinine; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Diabetic Nephropathies; Diabetic Retinopathy; Female; Fibrinogen; Humans; Lupus Coagulation Inhibitor; Male; Middle Aged; Thrombosis | 1997 |
Relationship between autonomic function and plasma fibrinogen, viscosity, and elements of fibrinolytic activity in diabetic nephropathy.
Topics: Adult; Aged; Autonomic Nervous System; Blood Viscosity; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Female; Fibrinogen; Fibrinolysis; Humans; Male; Middle Aged | 1997 |
[Fibrinogen and diabetic microangiopathy].
Topics: Adolescent; Adult; Blood Pressure; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Diabetic Nephropathies; Female; Fibrinogen; Humans; Male; Middle Aged; Platelet Aggregation | 1997 |
Altered red blood cell rheology as a predisposing factor for diabetic nephropathy.
Topics: Cholesterol; Diabetic Nephropathies; Erythrocyte Aggregation; Erythrocytes, Abnormal; Fibrinogen; Hematocrit; Humans; Rheology | 1998 |
Association of plasma fibrinogen level and blood pressure with diabetic retinopathy, and renal complications associated with proliferative diabetic retinopathy, in Type 2 diabetes mellitus.
Topics: Aged; Blood Pressure; Blood Viscosity; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diabetic Retinopathy; Female; Fibrinogen; Humans; Logistic Models; Male; Middle Aged | 1999 |
Relationship of abdominal fat with metabolic disorders in diabetes mellitus patients.
Topics: Abdomen; Adipose Tissue; Aged; Albuminuria; Antithrombin III; Blood Coagulation Disorders; Blood Pressure; Body Composition; Cholesterol, HDL; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Female; Fibrinogen; Humans; Insulin; Male; Middle Aged; Peptide Hydrolases; Regression Analysis; Sex Characteristics; Triglycerides; Viscera | 2002 |
[Regression of diabetic glomerular changes following islet transplantation. A study of rats with streptozotocin diabetes].
Topics: Animals; Complement C1; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Fibrinogen; Immunoglobulin G; Islets of Langerhans Transplantation; Kidney Glomerulus; Male; Microscopy, Fluorescence; Rats; Streptozocin; Transplantation, Homologous | 1979 |
Fibrinogen and FDP-E antigen deposits in nephritic kidneys.
Topics: Acute Disease; Adolescent; Adult; Aged; Antigen-Antibody Reactions; Antigens; Chronic Disease; Diabetic Nephropathies; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fluorescent Antibody Technique; Glomerulonephritis; Humans; Kidney Diseases; Kidney Glomerulus; Lupus Erythematosus, Systemic; Male; Middle Aged; Nephritis; Nephrosis, Lipoid | 1978 |
Blood and plasma viscosity in diabetes: possible contribution to late organ complications?
Topics: Adult; Aged; Albuminuria; Blood Viscosity; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Female; Fibrinogen; Hematocrit; Humans; Leg Ulcer; Male; Plasma; Reference Values | 1992 |
Effects of pentoxifylline on proteinuria in normotensive patients with diabetes mellitus.
Topics: Adult; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Fibrinogen; Humans; Male; Middle Aged; Pentoxifylline; Proteinuria | 1990 |
Plasma factor XIII and some other haemostasis parameters in patients with diabetic angiopathy.
Topics: Adult; Aged; alpha 1-Antitrypsin; alpha-Macroglobulins; Antithrombin III; Blood Coagulation; Complement C1 Inactivator Proteins; Diabetic Angiopathies; Diabetic Nephropathies; Factor XIII; Fibrinogen; Humans; Middle Aged; Plasminogen | 1986 |
Intraperitoneal heparin in peritoneal dialysis and its effect on fibrinopeptide A in plasma and dialysate.
Topics: Ascitic Fluid; Diabetic Nephropathies; Female; Fibrinogen; Fibrinopeptide A; Heparin; Humans; Kidney Failure, Chronic; Male; Peritoneal Dialysis, Continuous Ambulatory; Solutions | 1989 |
Abnormalities in plasmas concentrations of lipoproteins and fibrinogen in type 1 (insulin-dependent) diabetic patients with increased urinary albumin excretion.
Topics: Adult; Albuminuria; Blood Glucose; Blood Pressure; Cholesterol; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Fibrinogen; Glycated Hemoglobin; Humans; Lipoproteins; Middle Aged; Triglycerides | 1988 |
Metabolism of albumin and fibrinogen in type 1 (insulin-dependent) diabetes mellitus.
Topics: Adult; Albuminuria; Blood Pressure; Blood Proteins; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Female; Fibrinogen; Glycated Hemoglobin; Humans; Male; Reference Values; Serum Albumin | 1988 |
Effects of long-term treatment (4 years) with pentoxifylline on haemorheological changes and vascular complications in diabetic patients.
Topics: Adult; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Diabetic Retinopathy; Erythrocyte Deformability; Female; Fibrinogen; Humans; Male; Middle Aged; Pentoxifylline; Theobromine | 1987 |
Increased thromboplastic potential in diabetes: a multifactorial phenomenon.
Topics: Adult; Antithrombin III; Blood Coagulation Tests; Blood Glucose; Complement C1 Inactivator Proteins; Diabetes Mellitus; Diabetic Nephropathies; Diabetic Neuropathies; Diabetic Retinopathy; Fibrinogen; Humans; Platelet Aggregation; Thromboxane B2 | 1987 |
Hemodynamic alterations in long-term insulin-dependent diabetic patients with overt nephropathy: role of blood hyperviscosity and plasma protein changes.
Topics: Blood Proteins; Blood Viscosity; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Erythrocyte Deformability; Female; Fibrinogen; Fibronectins; Glomerular Filtration Rate; Hemodynamics; Humans; Male; Middle Aged; Proteinuria; Rheology | 1987 |
[Biochemical aspects of the pathogenesis of the late diabetic syndrome].
Topics: Apoproteins; Blood Glucose; Collagen; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Fibrinogen; Glycated Hemoglobin; Humans; Membrane Proteins; Myelin Proteins; Serum Albumin | 1985 |
Immunohistochemical studies in diabetic glomerulosclerosis.
Topics: Diabetic Nephropathies; Fibrinogen; Fluorescent Antibody Technique; Histocytochemistry; Humans; Hyalin; Kidney Glomerulus; Lipoproteins | 1966 |
Studies of diabetic glomerulosclerosis using an immunofluorescent technique.
Topics: Adolescent; Adult; Aged; Albumins; Animals; Cattle; Child; Complement System Proteins; Diabetic Nephropathies; Female; Fibrinogen; Fluorescent Antibody Technique; Goats; Guinea Pigs; Humans; Immune System Diseases; Immunoglobulin G; Insulin; Insulin Antibodies; Kidney Glomerulus; Lipoproteins, LDL; Male; Middle Aged; Rabbits; Serum Globulins | 1972 |
The role of fibrin deposition in diabetic glomerulosclerosis: a light, electron and immunofluorescence microscopy study.
Topics: Adult; Aged; Autopsy; Basement Membrane; Biopsy; Blood Pressure; Creatinine; Diabetic Nephropathies; Epithelium; Female; Fibrin; Fibrinogen; Fluorescent Antibody Technique; Histocytochemistry; Humans; Kidney Glomerulus; Male; Microscopy, Electron; Middle Aged; Nephrosclerosis; Proteinuria | 1972 |
A kinetic evaluation of hemostasis in renal disease.
Topics: Aspirin; Blood Coagulation; Complement System Proteins; Diabetic Nephropathies; Dipyridamole; Fibrin; Fibrinogen; Glomerulonephritis; Hemolytic-Uremic Syndrome; Heparin; Humans; Iodine Radioisotopes; Kidney; Kidney Diseases; Kidney Glomerulus; Kidney Transplantation; Plasminogen; Proteinuria; Thrombosis; Transplantation, Homologous; Uremia; Warfarin | 1974 |
Spontaneous immunoglobulin and complement deposition in glomeruli of diabetic rats.
Topics: Albumins; Animals; Complement System Proteins; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Fibrinogen; Immunoglobulin G; Immunoglobulins; Kidney; Kidney Glomerulus; Microscopy, Fluorescence; Rats | 1972 |
The role of coagulation in renal disease.
Topics: Acute Kidney Injury; Basement Membrane; Blood Coagulation Disorders; Diabetic Nephropathies; Disseminated Intravascular Coagulation; Female; Fibrin; Fibrinogen; Fibrinolysis; Glomerulonephritis; Hemagglutination Tests; Hemolytic-Uremic Syndrome; Humans; Ischemia; Kidney; Kidney Diseases; Male; Middle Aged; Pre-Eclampsia; Pregnancy; Thrombosis; Urokinase-Type Plasminogen Activator | 1973 |
Coagulability in diabetics.
Topics: Adolescent; Adult; Blood Coagulation; Blood Coagulation Tests; Calcification, Physiologic; Child; Child, Preschool; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Diabetic Nephropathies; Diabetic Retinopathy; Eye Manifestations; Factor V; Factor VII; Female; Fibrinogen; Heparin; Humans; Male; Methods; Middle Aged; Thrombin | 1967 |
Abnormal fibrin stabilization in renal failure.
Topics: Acute Kidney Injury; Cholelithiasis; Cholestasis; Diabetic Nephropathies; Factor XIII; Fibrin; Fibrinogen; Glomerulonephritis; Humans; Kidney Failure, Chronic; Nephrotic Syndrome; Pyelonephritis; Renal Dialysis; Tuberculosis, Renal; Uremia; Wound Healing | 1969 |